Fighting Depression with Targeted, Next Generation Psychedelics: A Conversation with Bright Minds CEO Ian McDonald Aug 14 • 8 min read We sat down with Ian McDonald, the CEO of Bright Minds, to learn more about what they’re working on and the future of psychedelic medicines.
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President Aug 14 • 6 min read Mind Medicine (MindMed) Inc. is opening a subsidiary in Switzerland, and has appointed Dr. Miri Halperin Wernli as it’s President
Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD Aug 13 • 5 min read Mydecine Innovations Group Inc. announced that NeuroPharm Inc., a company it has recently purchased, was covered in Forbes for it’s psilocybin clinical trials.
Yield Growth Announces Name Change and Provides Corporate Update Aug 13 • 5 min read The Yield Growth Corp announces that it will be changing its corporate name to Better Plant Sciences Inc.
GHP Noetic Science-Psychedelic Pharma Inc. Announces Closing of Initial Public Offering Aug 12 • 4 min read GHP Noetic Science-Psychedelic Pharma Inc. announced that it has completed its IPO of 5,000,000 shares.